SeaStar Medical Holding Corporation (ICUCW)
US — Healthcare Sector
Automate Your Wheel Strategy on ICUCW
With Tiblio's Option Bot, you can configure your own wheel strategy including ICUCW - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol ICUCW
- Rev/Share 0.0497
- Book/Share 0.0656
- PB 17.9985
- Debt/Equity 0.6425
- CurrentRatio 0.9647
- ROIC -19.0956
- MktCap 12218900.0
- FreeCF/Share -1.7606
- PFCF -0.8053
- PE -0.6394
- Debt/Assets 0.0478
- DivYield 0
- ROE 6.0184
- Rating C
- Score 2
- Recommendation Sell
- P/E Score 1
- DCF Score 5
- P/B Score 1
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| No ratings available. | |||||||
News
About SeaStar Medical Holding Corporation (ICUCW)
- IPO Date
- Website https://www.seastarmedical.com
- Industry Biotechnology
- CEO Mr. David A. Green CPA, M.B.A.
- Employees 19
SeaStar Medical Holding Corporation, a medical device company, focuses on providing novel solutions and services to treat hyperinflammation and cytokine storm in critically ill patients. The company is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. It is developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure with and without LVAD; myocardial stunning in end stage renal disease; and hepatorenal syndrome. The company is based in Denver, Colorado.